CAPN3 and Huntington disease: However, robust gene expression and prominent amounts of full-length CAPN3 protein were exhibited following the 6 × 1012 vg systemic dosage in the HD cohort, suggesting a dose-dependent response following AAVrh74.tMCK.hCAPN3 delivery (Figure 1B).